Prolactin
Research stageAlso known as Prl - Prolactin.
Recent clinical, regulatory, research and industry developments relating to this drug.
The role of maternal hormones in regulating autonomic functions during pregnancy.
Determinants of Maternal Insulin Resistance during Pregnancy: An Updated Overview.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- International journal of molecular sciences1
- Journal of cellular and molecular medicine1
- Journal of diabetes research1
- Journal of neuroendocrinology1
- Al-Farga A1
- Al-Gareeb AI1
- Al-Kuraishy HM1
- Alexiou A1
- Alghamdi OA1
- Alrouji M1
- Alshammari MS1
- Araujo-Castro M1
- Aarhus University Hospital1
- Centre for Neuroendocrinology and Department of Anatomy1
- College of Science1
- College of Science University of Jeddah1
- Damanhour University1
- Department of Clinical Laboratory Sciences1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 7 of the same disease areas as Prolactin in the shared literature.
Studied across 6 of the same disease areas as Prolactin in the shared literature.
Studied across 6 of the same disease areas as Prolactin in the shared literature.
Studied across 6 of the same disease areas as Prolactin in the shared literature.
Studied across 3 of the same disease areas as Prolactin in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature